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Objectives: The purpose of this study was to compare systemic inflammatory
responses after heart transplantation and nontransplant cardiac operations, both
involving cardiopulmonary bypass with a focus on the role of polymorphonuclear
leukocytes.
Methods: Lipid peroxidation, blood phagocyte radical production, and interleukin 6,
8, and 10 plasma concentrations during surgical intervention and on the first and
seventh postoperative days were evaluated in patients undergoing heart transplan-
tation (n  24) and in patients not undergoing transplantation (n  30).
Results: Levels of interleukin 6, 8, and 10 increased in both groups of patients
during early reperfusion. They normalized within the first postoperative day in the
transplant group, whereas the nontransplant group’s interleukin 6 and 8 levels
remained increased on the seventh day after the operation. Interleukin 10 plasma
levels were higher in the heart transplant group during reperfusion. Lipid peroxi-
dation was increased after the operation in both groups of patients. Phagocyte
activity was enhanced at reperfusion and at all other sampling times only in the
nontransplant group. On the other hand, phagocyte activity oscillated around the
preoperative level during heart transplantation, or it was even decreased.
Conclusion: Both cardiac operations involving heart transplantation and those
without transplantation are associated with increased oxidative stress and an en-
hanced production of proinflammatory and anti-inflammatory cytokines. Differ-
ences in interleukin 10 production and phagocyte activity could be caused mainly by
the immunosuppressive therapy in heart transplant operations.
Cardiac surgery involving cardiopulmonary bypass (CPB) is associ-ated with systemic inflammatory response, which is considered toaffect the clinical outcome of operations and could be caused byseveral factors, including the exposure of blood to the extracorpo-real circuit, postischemic reperfusion of the heart and lungs, andsurgical trauma.1-3 Mediators released during the inflammatory
response promote polymorphonuclear cell adhesion to the endothelial surface and
evoke their infiltration in tissues and the release of reactive oxygen species (ROS)
and enzymes.4,5 There are some important differences between the early phase of
heart transplantation (HTx) and nontransplant cardiac operations (non-HTx). Organ
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grafts are subjected to periods of both cold and warm
ischemia during storage and implantation, which extend the
duration of heart ischemia.6
Cytokines, such as interleukin 6 (IL-6) and IL-8, which
are known to be produced during cardiac operations, belong
to potent proinflammatory mediators with a wide range of
biologic activities.7,8 Their effects on neutrophils could ex-
acerbate both local and remote tissue damage.5,9 The extent
of their increase can be correlated with the severity of the
operation, and both cytokines have been suggested as mark-
ers with prognostic value for the outcome of the opera-
tion.3,6,7,10,11
Conversely, the anti-inflammatory cytokine IL-10, which
is also produced during human organ transplantation, has
been reported to downregulate the activity and release of
proinflammatory cytokines, including IL-6 and IL-8.12
Through these mechanisms, IL-10 can contribute to the
downregulation of the postreperfusion injury development
and systemic inflammatory response.8
The aim of this study was to better clarify interrelation-
ships among the plasma levels of IL-6, IL-8, and IL-10;
blood phagocyte ROS production; and oxidative stress-
induced damage in patients undergoing HTx and non-HTx.
The parameters from both groups of patients were com-
pared.
Materials and Methods
Patients
The study was approved by the local ethics committee, and verbal
informed consent was obtained from each subject. Only patients
undergoing HTx or non-HTx without complications during the
first postoperative week were selected, and their data were evalu-
ated. Indications for HTx were dilated cardiomyopathy (n  18)
and ischemic heart disease (n  6). Indications for non-HTx were
ischemic heart disease (n  19), aortic valve replacement (n  5),
and mitral valve replacement (n  6). The groups are described in
Table 1. Cold crystalloid cardioplegia (St Thomas Hospital solu-
tion) was used for cardiac preservation in both groups of patients.
In the HTx group the heart was perfused with 1000 mL of car-
dioplegic solution before donor cardiectomy. In the non-HTx
group, the total volume of cardiplegic solution used was 1300 mL
(median) with lower and upper quartiles of 1000 and 1500 mL,
respectively, depending on the crossclamping time. The postoper-
ative care was similar in both groups of patients, except for the
immunosuppressive therapy.
Immunosuppressive Protocol in the HTx Group
Generally, the immunosuppressive regimen consisted of azathio-
prine (1.5 mg/kg before transplantation and 3 mgkg1d1 on
days 1-2 after the operation reduced to 2 mgkg1d1 on days
3-7), methylprednisolone (500 mg before the operation and then
300 mg/d for the first 3 postoperative days), cyclosporine A (INN:
ciclosporin A; 0.5 mgkg1d1 on days 1-2 after the operation and
then maintained at 600-800 ng/mL blood on days 3-7), and pred-
nisone (0.6 mgkg1d1 on days 3-7).
Sampling and Determination of Cytokine and Lipid
Peroxide Levels
Heparinized peripheral blood samples were taken from the patients
before the operation; at the time of reperfusion; 30 minutes, 4
hours, and 24 hours after reperfusion; and on the seventh day after
the operation. Total and differential counts, hematocrit levels, and
the oxidative burst of phagocytes were determined immediately.
Plasma samples for cytokine and lipid peroxidation detection were
frozen and stored at 30°C. Plasma levels of cytokines were
determined by using commercially available enzyme-linked im-
munosorbent assay kits from R&D Systems (Quantikine IL-6,
IL-8, and IL-10). The detection limit for cytokine levels was 5
pg/mL. The concentration of thiobarbituric acid reactive sub-
stances, which is the index of lipid peroxidation, was determined
spectrophotometrically.13
Oxidative Burst of Phagocytes
Luminol-enhanced chemiluminescence of whole-blood phago-
cytes was measured with a Luminometer LM-01T (Immunotech),
as described previously.4 The principle of the method is based on
luminol interaction with the phagocyte-derived free radicals,
which results in large measurable amounts of light. Spontaneous
and opsonized zymosan particle (OZP)-activated chemilumines-
cence was measured for 60 minutes at 37°C. The integral value of
the chemiluminescence reaction, which represents the total ROS
production by the blood phagocytes, was corrected for 103 neu-
trophil granulocytes.
Statistical Analysis
Data were not normally distributed, and therefore nonparametric
statistical methods were used (Statistica for Windows 5.0, StatSoft,
Inc). Data are expressed as medians and lower and upper quartiles.
At each time point, the Mann-Whitney U test was applied to
compare the groups of patients. The Wilcoxon test was used for the
inspection of differences between preoperative values and differ-
ent time points within each group. Interrelationships among vari-
ables were assessed by using the Pearson correlation test.
Results
Time Profiles of Cytokine Levels
Plasma levels of IL-6, IL-8, and IL-10 were increased in
patients undergoing HTx at the time of reperfusion, with
TABLE 1. Clinical data on the HTx and non-HTx groups
HTx group Non-HTx group
Age (y) 46.0 (44.5; 54.5) 63.0* (55.0; 72.0)
Sex ratio (male/female) 21:3 15:15
CPB time (min) 103.0 (88.5; 125.0) 66.5† (58.0; 85.0)
Ischemic time (min) 164 (147; 202) 36* (31; 52)
Data are expressed as medians and lower and upper quartiles, except the
sex ratio, which is expressed as the number of patients. Asterisks mark
significant differences between the HTx and non-HTx groups (Mann-
Whitney U test; *P  .001; †.001  P  .01). The term ischemic time
denotes the graft ischemic time in the HTx group or the aortic crossclamp-
ing time in the non-HTx group.
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further remarkable increases 30 minutes after reperfusion
(Figure 1). Whenever a stimulation of IL release occurred,
it decreased sharply 24 hours after reperfusion and returned
to preoperative levels on the seventh day after the operation.
All the observed cytokines were increased in a similar
pattern in the non-HTx group. However, IL-6 and IL-8
plasma levels reached their peak values later (4 hour after
reperfusion) and did not return to the preoperative levels on
the seventh day after the operation in the non-HTx group.
The plasma levels of IL-6 were higher in the HTx group
Figure 1. Time profiles of IL-6 (A), IL-8 (B), and IL-10 (C) plasma levels. The ordinate represents actual values in both
the HTx (open triangles) and non-HTx (filled circles) groups at different sampling times: before the operation; at
the time of reperfusion; 30 minutes, 4 hours, and 24 hours after reperfusion; and 7 days after operation. Asterisks
mark the sampling times when the values of a specified parameter differed significantly between the HTx (n 24)
and non-HTx (n  30) groups (Mann-Whitney U test; ***P < .001; **.001 < P < .01; *.01 < P < .05). Crosses mark
the sampling times when the values of a specified parameter differed significantly from the preoperative values
(Wilcoxon matched paired test; P < .001; .001 < P < .01; .01 < P < .05).
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than in the non-HTx group in the early phase of reperfusion
(up to 30 minutes after reperfusion), whereas IL-6 levels
were higher in the non-HTx group 24 hours after reperfu-
sion (Figure 1, A). The plasma levels of IL-8 did not
remarkably differ between the HTx and non-HTx groups
(Figure 1, B). IL-10 plasma levels were higher in the HTx
group than in the non-HTx group from reperfusion to 4
hours after reperfusion (Figure 1, C).
Time Course of Changes in Total and Differential
Counts of Leukocytes
Total leukocyte counts were increased in both groups of
patients from reperfusion to the seventh day after the oper-
ation when compared with the preoperative levels (Figure 2,
A). Leukocyte numbers were higher in the HTx group at all
sampling intervals.
The sharp increase in the total number of leukocytes was
associated with a relative increase in neutrophils (mainly of
not fully maturated neutrophils; Figure 2, B). They in-
creased remarkably at the time of reperfusion and remained
higher up to 24 hours after reperfusion in both groups of
patients. The percentage of segmented-maturated neutro-
phils was increased from the time of reperfusion to 24 hours
after reperfusion only in the non-HTx group (Figure 2, C).
In the HTx group the segmented neutrophils were increased
only 24 hours after reperfusion and on the seventh day after
the operation.
Time Profiles of Spontaneous and Activated
Chemiluminescence
Spontaneous chemiluminescence was decreased during
reperfusion and 30 minutes after reperfusion in the HTx
group when compared with the preoperative level (Figure 3,
A). After that, the chemiluminescence activity oscillated
around the preoperative value. On the other hand, sponta-
neous chemiluminescence was increased when compared
with its preoperative levels in the non-HTx group at all
sampling intervals. OZP-activated chemiluminescence was
not increased to greater than the preoperative level in the
HTx group at any of the sampling intervals (Figure 3, B).
However, in the non-HTx group the activated chemilumi-
nescence was increased at all sampling intervals compared
with the preoperative level. Both spontaneous and OZP-
activated chemiluminescence were higher in the non-HTx
group than in the HTx group at all perioperative and post-
operative sampling times.
Time Course of Malondialdehyde Concentration
Plasma levels of thiobarbituric acid reactive substances
were increased 30 minutes and 4 hours after reperfusion in
both groups of patients (Table 2).
Correlation Among Monitored Parameters
Correlation analysis detected positive correlation between
IL-6 and IL-8 in samples from both the HTx and non-HTx
groups at the time of reperfusion and 30 minutes, 4 hours,
and 24 hours after reperfusion (Table 3). No other consistent
correlations were found among the evaluated parameters.
Discussion
Cardiac operations involving CPB is associated with a sys-
temic inflammatory response, which is an extremely com-
plex phenomenon related to the release of various cyto-
kines.1 Their release can be triggered by many factors, such
as surgical procedure, duration of the ischemia and reper-
fusion in the heart, exposure of blood to the extracorporeal
circuit, or release of endotoxin.6 The release of cytokines is
important because such a release is implicated in the devel-
opment of postoperative complications.2,3,7,8,11,14 A better
understanding of cytokine responses might lead to new
therapeutic implications.
The increase in the plasma levels of IL-6, IL-8, and IL-10
within the early phase of reperfusion in patients undergoing
cardiac operations involving CPB has already been de-
scribed in many studies.3,5,6,9-12,15-17 However, only several
studies have evaluated these parameters in patients under-
going HTx18,19 or compared both groups of patients.6 The
cytokine levels mostly normalized within the first or second
postoperative days in both HTx and cardiac operations.
These results were confirmed in our study, in which IL-6,
IL-8, and IL-10 kinetics were measured during and after
HTx and non-HTx operations involving CPB. Heart storage
and longer duration of acute ischemia starting from aortic
crossclamping are important factors differentiating the early
phase of HTx from non-HTx.6 Therefore a stronger inflam-
matory response might be expected during HTx. On the
other hand, the HTx group received the immunosuppressive
drugs azathioprine and methylprednisolone during the op-
eration. It is well documented that early steroid administra-
tion before CPB can reduce the inflammatory response and
enhance the release of IL-10.8,10,18,20
We found IL-6 and IL-8 plasma concentrations to be
approximately on the same level in both groups of patients.
On the other hand, the plasma concentration of IL-10 was
remarkably higher in the HTx group. Therefore we suggest
that immunosuppressive therapy prevented the expected
more intensive release of IL-6 and IL-8 in these patients. To
the contrary, the extended IL-10 release in the HTx group
could also be caused by both immunosuppressive therapy
and a more profound ischemic period. The absence of
immunosuppressive therapy in the non-HTx group might be
a reason for the higher IL-6 and IL-8 concentrations found
in these patients on day 7 after the operation. Contrary to
our results, Wan and colleagues6 found higher IL-8 and IL-6
release in patients having undergone HTx than in patients
after non-HTx. IL-10 was at the same level in both groups.
In our study the cytokine levels and blood phagocyte ROS
production had relatively low variability before surgical
treatment and did not differ significantly between the 2
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groups of patients. However, a relatively high variability of
the parameters studied was observed in each group of pa-
tients during the perioperative and postoperative periods.
Patients in the HTx group were younger than those in the
non-HTx group, but there is no evidence that the cytokine
release is influenced by age.6,15 The duration of CPB and the
Figure 2. Time profiles of leukocyte counts. Panel A shows the total leukocyte counts corrected for hemodilution.
Panel B shows the relative counts of not fully maturated neutrophils (bars), and panel C shows the relative counts
of fully maturated neutrophils (segments). The ordinate represents actual values in both the HTx (open triangles)
and non-HTx (filled circles) groups at different sampling times: before the operation; at the time of reperfusion; 30
minutes, 4 hours, and 24 hours after reperfusion; and 7 days after operation. Asterisks mark the sampling times
when the values of a specified parameter differed significantly between the HTx (n  24) and non-HTx (n  30)
groups (Mann-Whitney U test; ***P < .001; **.001 < P < .01; *.01 < P < .05). Crosses mark the sampling times
when the values of a specified parameter differed significantly from the preoperative values (Wilcoxon matched
paired test; P < .001; .001 < P < .01; .01 < P < .05).
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ischemic period (starting from aortic crossclamping on the
donor heart in the HTx group) was longer in the HTx group
than in the non-HTx group. Several authors have found a
correlation between the ischemic period or the duration of
CPB and IL-6 or IL-8 concentrations.6,10,11,14 It suggests an
important role of ischemia duration, as well as a role of the
inflammatory consequences of longer periods in which
blood is exposed to artificial materials or abnormal shear
Figure 3. Time profiles of spontaneous (A) and OZP-activated (B) whole-blood chemiluminescence activities of
phagocytes. The ordinate represents actual values in both the HTx (open triangles) and non-HTx (filled circles)
groups at different sampling times: before the operation; at the time of reperfusion; 30 minutes, 4 hours, and 24
hours after reperfusion; and 7 days after operation. Asterisks mark the sampling times when the values of a
specified parameter differed significantly between the HTx (n  24) and non-HTx (n  30) groups (Mann-Whitney
U test; ***P < .001; **.001 < P < .01. Crosses mark the sampling times when the values of a specified parameter
differed significantly from the preoperative values (Wilcoxon matched paired test; P < .001; .001 < P <
.01).
TABLE 2. Time profiles of lipid peroxidation
Patients
Sampling times
Before Reperfusion 30 min 4 h 24 h 7 d
TBARS
(mol/L)
HTx 6.1 (3.7; 8.2) 6.2 (4.4; 8.3) 8.0 (6.6; 11.3)* 8.8 (5.0; 11.1)* 6.8 (4.4; 8.6) 6.5 (5.3; 8.1)
Non-HTx 5.6 (3.4; 8.2) 6.2 (4.2; 8.2) 8.1 (4.9; 11.4)* 8.4 (5.1; 12.0)* 5.8 (3.6; 8.1) 6.0 (3.9; 6.2)
Time profiles of the Thiobarbituric acid reactive substances plasma concentrations in both the HTx (n  24) and non-HTx (n  30) groups of patients at
different sampling times: before the operation; at the time of reperfusion; 30 minutes, 4 hours, and 24 hours after reperfusion; and 7 days after the operation.
Data are expressed as medians and lower and upper quartiles. Asterisks mark the sampling times when the values of a specified parameter differed
significantly from the preoperative values (Wilcoxon matched paired test; *.001  P  .01).
TBARS, Thiobarbituric acid reactive substances.
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forces.6,10,11 On the other hand, no correlation was found
with IL-10.6,12,17 Some authors failed to find any correlation
between the peak levels of IL-6 or IL-8 and CPB or aortic
crossclamping duration.3,9
The site of cytokine release during and after HTx and
non-HTx is unclear. Fujiwara and associates3 suggested that
cytokines in serum did not originate from a specific location
and that they could be released from leukocytes, macro-
phages, endothelial cells of systemic vasculature, or the
parenchyma of tissue, such as muscles. On the other hand,
the myocardium was suggested as an important source of
IL-6 and IL-8 in CPB after reperfusion of the heart,8 and
hypoperfused liver has been shown to be the main source of
IL-10 during CPB.12 We found a positive correlation be-
tween the plasma levels of IL-6 and IL-8 in both groups of
patients, which suggests an activation of their common
source (monocytes-macrophages). Although the kinetics of
IL-6, IL-8, and IL-10 releases measured in individual
groups of patients were similar, no correlation with IL-10
was found. Frering and coworkers9 failed to observe any
correlation between IL-6 and IL-8 levels in patients after
CPB. On the other hand, Wan and associates12 found a
positive correlation between IL-10 plasma levels and IL-8
and IL-6 in the non-HTx group.
In the present study a remarkable increase in lipid per-
oxidation measured on the basis of thiobarbituric acid reac-
tive substances has been found in both groups of patients 4
and 24 hours after the operation. At the cellular level, the
excessive oxidative stress causes damage of cell membrane
lipids (lipid peroxidation), denaturation of proteins, break-
down of carbohydrates, and, consequently, lysis of endo-
thelium and tissue injury.21 Our results are consistent with
several previous studies in which oxidative stress and sub-
sequent lipid peroxidation were demonstrated in patients
undergoing cardiac operations involving CPB.16,21-24
In our study the significant increase in leukocyte num-
bers was observed in both groups of patients starting at the
beginning of the operation. The higher leukocyte numbers
in the HTx group were found at all sampling intervals, and
this difference could result from the high doses of steroids
in the HTx group.25 An inhibitory effect of methylpred-
nisolone on neutrophil sequestration in the pulmonary vas-
cular system has been shown by other authors.26 Activated
polymorphonuclear leukocytes, which are sequestered into
the pulmonary circulation and produce increased amounts
of ROS, have been shown to be a causal factor of CPB’s
deleterious effects.5,7,14 We confirmed, in this study, the
results from our previous study that the blood phagocyte
ROS production is remarkably increased during reperfusion
up to the seventh postoperative day in patients undergoing
cardiac operations.4 The concurrent increase in neutrophil
numbers, together with their boosted metabolic activity,
contributed to the increased ROS production. Neutrophil
priming with an increased production of superoxide during
CPB has also been described by other authors.27,28 On the
contrary, we have not found any increase in activated ROS
production (spontaneous ROS production was even re-
duced) at an early phase of reperfusion in patients in the
HTx group. It means that although neutrophil numbers were
increased, their metabolic activity was suppressed. One of
the possible explanations is the relative increase of not fully
maturated neutrophils with lower potential of ROS produc-
tion, whereas fully maturated neutrophils remained without
a change at early times of reperfusion in patients in the HTx
group. On the other hand, the relative counts of both forms
of neutrophils were increased at these time intervals in the
non-HTx group. Another possible explanation for the de-
pressed activity of blood phagocytes in the HTx group could
be the immunosuppressive therapy. There is a lack of stud-
ies describing the influence of immunosuppressive agents
on the spontaneous and activated oxidative burst of phago-
cytes. However, we did not confirm a direct effect of im-
munosuppressive agents on the production of ROS by neu-
trophils in in vitro experiments in our previous study.29
Another possible explanation could be an influence of IL-10
on ROS production by blood phagocytes. There have been
some reports showing inhibitory effects of IL-10 on the
activity and ROS production by phagocytes,30 but contrary
reports also exist.31 We did not confirm a direct effect of
IL-10 on the whole-blood production of ROS in in vitro
experiments in concentrations up to 10 times higher than the
average levels occurring during operations (unpublished
data). The low chemiluminescence reactivity of phagocytes
during HTx remains to be elucidated.
TABLE 3. Interrelationships between IL-6 and IL-8 at the time of reperfusion, 30 minutes after reperfusion, 4 hours after
reperfusion, and 24 hours after reperfusion in the HTx and non-HTx groups
Patients
Sampling times
Reperfusion 30 min 4 h 24 h
IL-6  IL-8 correlation HTx 0.505 0.703 0.645 0.747
P  .02 P  .001 P  .002 P  .001
Non-HTx 0.510 0.618 0.642 0.548
P  .004 P  .001 P  .001 P  .001
The values of the Spearman correlation coefficient with level of significance are shown for each sampling time.
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In conclusion, we proved that the processes associated
with HTx and non-HTx operations involving CPB are con-
nected with increased oxidative stress and with increased
production of both proinflammatory and anti-inflammatory
cytokines. Concentrations of proinflammatory cytokines
were on the same level in both groups, whereas the anti-
inflammatory IL-10 level was higher in the non-HTx group.
We confirmed the contribution of circulating phagocytes to
the increased oxidative stress in the non-HTx group. On the
contrary, the activity of circulating phagocytes was de-
pressed in patients in the HTx group. The observed differ-
ences between HTx and non-HTx operations could be
caused mainly by the immunosuppressive therapy in HTx
operations. However, other factors, such as a longer dura-
tion of ischemia in HTx, could be involved.
We thank Dr Blaha for his statistical guidance and analysis of
the study.
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